SBC Medical Group Holdings Incorporated - Common Stock (SBC)
4.0400
-0.0900 (-2.18%)
NASDAQ · Last Trade: Aug 26th, 3:18 PM EDT
Detailed Quote
Previous Close
4.130
Open
4.200
Bid
4.030
Ask
4.120
Day's Range
4.020 - 4.212
52 Week Range
2.620 - 12.50
Volume
15,021
Market Cap
-
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
43,559
Chart
About SBC Medical Group Holdings Incorporated - Common Stock (SBC)
SBC Medical Group Holdings is a healthcare company focused on advancing medical technologies and services. The organization is dedicated to developing innovative solutions aimed at improving patient outcomes, enhancing the efficiency of healthcare delivery, and addressing various medical needs across different specialties. Through a combination of research, development, and strategic partnerships, SBC Medical Group Holdings aims to drive progress in medical practices and the overall healthcare landscape. Their commitment to quality and excellence positions them as a key player in the evolving medical sector. Read More
DETROIT, MICHIGAN - August 26, 2025 ( NEWMEDIAWIRE ) - SBC Medical Group Holdings Inc. (NASDAQ: SBC), the Japanese owner and operator of a chain of cosmetic surgery clinics, continued to execute its strategic strategy shift during the first six months of the year, including expanding the number of franchise locations and visits among customers.
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that Dr. Ewen Chee, founder of Singapore’s leading aesthetic medical company Aesthetic Healthcare Holdings (“AHH”), has been appointed President of AHH and Lead Doctor for Asia Strategy at SBC Medical Group. In this role, Dr. Chee will support physician recruitment and training across the Asia-Pacific region, contributing to SBC’s global strategy.
SBC Medical Group's Q2 2025 results missed estimates with revenue down 18% and EPS at $0.02. Franchise growth and customer loyalty offer long-term hope despite short-term challenges.
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global franchise and provider of services for aesthetic clinics, today announced that it will report its Q2 2025 financial results on Wednesday, August 13, 2025, before the U.S. market opens.
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global franchise and provider of services for aesthetic clinics, announced that, on July 17, 2025, it acquired MB career lounge, Co., Ltd. (“MB career lounge”), a privately-held provider of management support services for medical institutions, specializing in consulting, training, and human resources solutions in Japan, through a share purchase transaction for cash consideration.
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced the appointment of Dr. Steven R. Cohen, a globally recognized leader in plastic and craniofacial surgery, as Medical Strategy Advisor. His appointment marks a significant step in the company’s strategy to expand its global footprint and enhance its medical excellence.
DETROIT, MICHIGAN - July 9, 2025 ( NEWMEDIAWIRE ) - SBC Medical Group Holdings Inc. (NASDAQ: SBC), a global franchise and provider of services for aesthetic clinics, is making inroads on the investor front, recently being added to the broad-market Russell 3000® Index. As of the close of trading on June 30, SBC Medical Group was part of the 2025 Russell indexes reconstitution.
DETROIT, MICHIGAN - July 9, 2025 ( NEWMEDIAWIRE ) - SBC Medical Group Holdings Inc. (NASDAQ: SBC), a global franchise and provider of services for aesthetic clinics, is making inroads on the investor front, recently being added to the broad-market Russell 3000® Index. As of the close of trading on June 30, SBC Medical Group was part of the 2025 Russell indexes reconstitution.
IRVINE, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, is pleased to announce the appointment of Shinya Inoue as Chief Marketing Officer (CMO), effective July 1, 2025.
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution.
IRVINE, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, recently participated in several prominent investor conferences throughout May and June 2025. SBC Medical delivered webcast presentations and conducted one-on-one meetings with institutional investors.
IRVINE, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global franchise and provider of services for aesthetic clinics, today announced its upcoming investor event attendance.
DETROIT, MICHIGAN - May 20, 2025 ( NEWMEDIAWIRE ) - SBC Medical Group Holdings Inc. (NASDAQ: SBC), the Japanese owner and operator of a chain of cosmetic surgery clinics, is in transformation mode, overhauling its pricing structure and adapting to a changing marketplace, which seems to have paid off in the company’s first quarter.
SBC Medical Group Holdings Incorporated (NASDAQ: SBC, “SBC Medical” or the “Company”), a global owner, operator and provider of management services and products to cosmetic treatment centers, today announced its financial results for the three months ended March 31, 2025.
IRVINE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings (Nasdaq: SBC, “the Company”) today announces that its Board of Directors has approved the following share repurchase program and will commence repurchasing its own shares as early as May 20, 2025.
